An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index.
Abstract
Oxidative stress has been linked with a variety of diseases, being involved in the debut and/or progress of several neurodegenerative disorders. This review intends to summarize some of the findings that correlate the overproduction of reactive oxygen species with the pathophysiology of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. Oxidative stress was also noted to modify the inflammatory response. Even though oxidative stress and neuroinflammation are two totally different pathological events, they are linked and affect one another. Nonetheless, there are still several mechanisms that need to be understood regarding the onset and the progress of neurodegenerative diseases in order to develop efficient therapies. As antioxidants are a means to alter oxidative stress and slow down the symptoms of these neurodegenerative diseases, the most common antioxidants, enzymatic as well as non-enzymatic, have been mentioned in this paper as therapeutic options for the discussed disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Generally known reactive oxygen species (ROS). Adapted from [13].](https://figures.cochat.ai/paper-figures/9dc1d012e9e34e18822030ec89569bfb/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-1.jpg)
![Figure 2 Dopamine metabolism and ROS production. Reprinted from an open-access source [21].](https://figures.cochat.ai/paper-figures/3cc9438ebe354aeab026d8ea3f0ad7cc/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-2.jpg)
![Figure 3 Schematic representation of alterations in dopamine, iron, and alfa-synuclein promoting oxidative stress in the substantia nigra pars compacta. Reprinted from an open-access source [21].](https://figures.cochat.ai/paper-figures/79d7743213bd4acd8dc276da40dae43e/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-3.jpg)
![Figure 4 The model of motor nerve terminal dysregulation in ALS. (A) Healthy NMJ. (B) Pathological changes in NMJ during early stage of ALS. (C) Pathological changes in NMJ during late stage of ALS. Abbreviations: Ach—acetyl choline, MuSK—muscle-specific kinase, NMJ—neuromuscular junction, ROS—reactive oxygen species, TSC—terminal Schwann. Reprinted from an open-access source [34].](https://figures.cochat.ai/paper-figures/2e64b95026e34c5ab6b7ccd689373902/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-4.jpg)
![Figure 5 Representation of ROS-induced mitochondrial abnormalities in AD. Reprinted from an open-access source [9].](https://figures.cochat.ai/paper-figures/43a7b1a13867494ca7957071279194b2/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-5.jpg)
![Figure 6 Mutant HTT (mHTT)-induced mitochondria-mediated reactive oxygen species (ROS) accumulation. Adapted from [62].](https://figures.cochat.ai/paper-figures/b96903214a6042b4b49c7465333ed8f1/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-6.jpg)
![Figure 7 Overview of microglial functions in response to stress and AD pathology. Adapted from [71].](https://figures.cochat.ai/paper-figures/982c0e0a6c73429884ec1275432bb076/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within this context, ω3 are able to ameliorate oxidative stress and neuroinflammation, which may explain part of their beneficial effects on PD [457].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [457]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
Ighodaro, O. M., & Akinloye, O. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 3,939
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 4×
“In more detail, high oxygen consumption, low antioxidant levels, and low regenerative capacity were observed to induce oxidative damage susceptibility in brain tissues [7].”
BackgroundInfluentialOxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,254
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · cited 1×
“Moreover, due to the lowering of estrogen levels during menopause and longer life expectancy, women are more likely to develop AD than men [42,43].”
BackgroundOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · cited 2×
“sible for learning and memory, which are affected in AD brains [48].”
BackgroundA blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853 · cited 1×
“Because the therapeutic agents need to reach the central nervous system (CNS), it is necessary to tailor appropriate vectors that can surpass the brain–blood barrier (BBB) [3,6].”
BackgroundHardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 1,414
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · cited 9×
“dehydrogenase, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) [13,15].”
BackgroundInfluential13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215
Cited by
Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 700
“Scientists hope to discover new paths for therapy and prevention by better understanding the complicated interplay between oxidative stress and neurological disorders, thereby enhancing the quality of life for people affected by these conditions 6 .”
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Tumilaar, S. G., Hardianto, A., Dohi, H., & Kurnia, D. (2024) · Journal of Chemistry · doi:10.1155/2024/5594386 · Cited by 265
Oxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics
Dhapola, R., Beura, S. K., Sharma, P., Singh, S. K., & HariKrishnaReddy, D. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09021-z · Cited by 252
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Al-Ghraiybah, N. F., Wang, J., Alkhalifa, A. E., Roberts, A. B., Raj, R., Yang, E., & Kaddoumi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810572 · Cited by 202
“In addition to stress, heavy metal toxicity could increase neuroinflammation by acting as catalytic agents for redox reactions, thus, increasing oxidative stress [49,50]; alternatively, heavy metals could cause protein misfolding [51,52].”
BackgroundRole of Oxidative Stress in Blood–Brain Barrier Disruption and Neurodegenerative Diseases
Kim, S., Jung, U. J., & Kim, S. R. (2024) · Antioxidants · doi:10.3390/antiox13121462 · Cited by 208
“Oxidative stress is a hallmark feature of the brain in neurodegenerative diseases, characterized by the excessive production of ROS that overwhelms the brain’s antioxidant defenses [13,14,16,18,20,21,28].”
Selvaraj, N. R., Nandan, D., Nair, B. J. B., Nair, V. A., Venugopal, P., & Aradhya, R. (2025) · Cells · doi:10.3390/cells14070511 · Cited by 176
“Trx protects neurons against oxidative stress, with decreased levels observed in Parkinson’s disease (PD) and AD [230].”
Oxidative stress: The nexus of obesity and cognitive dysfunction in diabetes
Li, H., Ren, J. L., Li, Y., Wu, Q., & Wei, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1134025 · Cited by 203
“An imbalance in redox and insufficient inflammatory response in the central nervous system causes neuroinflammation (116).”
BackgroundInfluentialTripathi, P., Lodhi, A., Rai, S., Nandi, N., Dumoga, S., Yadav, P., Tiwari, A., Singh, S., El-Shorbagi, A.-N., & Chaudhary, S. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s452009 · Cited by 146
Valotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., et al. (2024) · Antioxidants · doi:10.3390/antiox13040393 · Cited by 146
Ciuca, M. D., & Racoviţă, R. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108874 · Cited by 154
Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
Tian, E., Sharma, G., & Dai, C. (2023) · Antioxidants · doi:10.3390/antiox12101883 · Cited by 144
Mitophagy and cGAS–STING crosstalk in neuroinflammation
Zhou, X., Wang, J., Yu, L., Qiao, G., Qin, D., Yuen-Kwan Law, B., Ren, F., Wu, J., & Wu, A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.012 · Cited by 131
PPAR agonists for the treatment of neuroinflammatory diseases
Titus, C., Hoque, M. T., & Bendayan, R. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.11.004 · Cited by 138
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Li, Y.-B., Fu, Q., Guo, M., Du, Y., Chen, Y., & Cheng, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03075-8 · Cited by 113
Lü, Y., Bu, F., Wang, F., Liu, L., Zhang, S., Wang, G., & Hu, X. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00341-5 · Cited by 135
“Despite the differences in neurobiology, the age-related and disease-related cognitive dysfunction are consistent in pathophysiological features, including neuroinflammation, oxidative stress, mitochondrial dysfunction and metabolic alterations [15, 16].”
BackgroundKim, S., Jung, U. J., & Kim, S. R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020386 · Cited by 150
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
Scarian, E., Viola, C., Dragoni, F., Gerlando, R. D., Rizzo, B., Diamanti, L., Gagliardi, S., Bordoni, M., & Pansarasa, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052698 · Cited by 129
Sanaeifar, F., Pourranjbar, S., Pourranjbar, M., Ramezani, S., Mehr, S. R., Wadan, A. S., & Khazeifard, F. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112539 · Cited by 132
Han, Y., Liu, X., Jin, M., Sun, H., & Kwon, T. (2023) · Inflammation Research · doi:10.1007/s00011-023-01790-4 · Cited by 120
“Pathological protein deposition [32], neuroin-flammation [33], and oxidative stress [34] are hypothesized to cause neuronal death.”
BackgroundGutiérrez-Pacheco, M. M., Moreno, H. T., Flores-López, M. L., Velázquez‐Guadarrama, N., Ayala-Zavala, J. F., Ortega-Ramírez, L. A., & López-Romero, J. C. (2023) · Antibiotics · doi:10.3390/antibiotics12111608 · Cited by 117
The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene
Kulawik, A., Cielecka‐Piontek, J., & Zalewski, P. (2023) · Nutrients · doi:10.3390/nu15173821 · Cited by 112
Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)
Qin, P., Sun, Y., & Li, L. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5371 · Cited by 114
“Conversely, normal cells also possess a protective system against free radicals, primarily composed of antioxidant enzymes such as glutathione peroxidase (GPX), non‑enzymatic antioxidant factors, superoxide dismutase (SOD) and catalase (33).”
BackgroundInfluentialNovel potential pharmacological applications of dimethyl fumarate—an overview and update
Bresciani, G., Manai, F., Davinelli, S., Tucci, P., Saso, L., & Amadio, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1264842 · Cited by 105
“, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, are characterized, among other features, by inflammation, oxidative stress, and the slow, progressive death of neurons (Guo et al., 2022; Teleanu et al., 2022).”
BackgroundKarvandi, M. S., Hesari, F. S., Aref, A. R., & Mahdavi, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1105247 · Cited by 114
“In parallel with this, high expression levels of chemokines, interleukins, interferons, and tumor necrosis factor-α (TNF-α) have been discovered in the striatum and substantia nigra of PD post-mortem brain samples and CSF of AD patients (Hirsch and Hunot, 2009; Llano et al., 2012; Gelders et al., 2018).”
BackgroundInfluentialROS homeostasis in cell fate, pathophysiology, and therapeutic interventions
Chen, Y.-S., Tian, H., Rong, D., Wang, L., Chen, S., Zeng, J., Xu, H., Mei, J., Wang, L.-Y., Liou, Y., et al. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00338-8 · Cited by 112
“The underlying molecular mechanisms involve direct ROS-induced oxidative damage to neuronal lipids, proteins and DNA [331], as well as ROS-mediated oxidative modifications that crucially promote the aberrant aggregation of toxic proteins [332].”
Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation
Müller, L., & Di Benedetto, S. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1575022 · Cited by 77
“Chronic oxidative stress exacerbates neuroinflammatory signaling, creating a vicious cycle that accelerates disease progression (Teleanu et al., 2022).”
Suresh, S., Ankul Singh, S., Rushendran, R., Vellapandian, C., & Prajapati, B. G. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1303111 · Cited by 99
“Therefore, the inflammatory response fails to properly function, causing central nervous system inflammation (82).”
Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders
García‐Domínguez, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060417 · Cited by 105
“This pathological state contributes to increased oxidative stress, glutamate-mediated excitotoxicity, and dysregulated synaptic activity [153–155].”
Korte, N., Barkaway, A., Wells, J. A., Freitas, F., Sethi, H., Andrews, S. P., Skidmore, J., Stevens, B., & Attwell, D. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01753-w · Cited by 109
“To test whether >3rd order pericytes can contract (as may occur in ischemic and AD cortex where levels of vasoconstrictors, such as ROS, are elevated 37,38 ), we induced two-photon laser parenchymal injuries generating ROS 39 , with Article https://doi.org/10.1038/s41593-024-01753-w the laser beam…”
BackgroundInfluentialMartinez, R. M., Melo, C. P. B., Pinto, I. C., Mendes-Pierotti, S., Vignoli, J. A., Verri, W. A., Jr., & Casagrande, R. (2024) · Foods · doi:10.3390/foods13233909 · Cited by 107
“Oxidative stress can activate inflammatory pathways, accelerating neuronal damage and disease progression [85].”
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Du, F., Li, J., Zhang, S., Zeng, X., Nie, J., & Li, Z. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18486 · Cited by 99
Resveratrol as a privileged molecule with antioxidant activity
Constantinescu, T., & Mihis, A. G. (2023) · Food Chemistry Advances · doi:10.1016/j.focha.2023.100539 · Cited by 93
Effects of choline containing phospholipids on the neurovascular unit: A review
Roy, P., Tomassoni, D., Nittari, G., Traini, E., & Amenta, F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.988759 · Cited by 86
“Neuroinflammatory response, oxidative stress, protein homeostasis, and apoptotic signaling are involved in the cognitive decline and in the development of neurodegenerative disorders (Teleanu et al., 2022).”
BackgroundChen, Y., Yang, Z. R., Nian, B., Yu, C., Maimaiti, D., Chai, M., Yang, X., Zang, X., & Xu, D. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s479757 · Cited by 89
Oxidative stress and ion channels in neurodegenerative diseases
Orfali, R., Alwatban, A. Z., Orfali, R. S., Lau, L., Chea, N., Alotaibi, A. M., Nam, Y.-W., & Zhang, M. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1320086 · Cited by 86
“Although neurodegenerative disorders have distinct etiologies and develop in different brain sites, recent studies have observed that their effects on cellular and molecular mechanisms are similar (Aborode et al., 2022; Gates et al., 2022; Teleanu et al., 2022; Rehman et al., 2023).”
BackgroundµMap proximity labeling in living cells reveals stress granule disassembly mechanisms
Pan, C., Knutson, S. D., Huth, S. W., & MacMillan, D. W. C. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01721-2 · Cited by 88
“Enriched granule interactors ( n = 698, log 2 (fold change) > 0.5, P 0.05) drawn from comparisons between the HaloTag–G3BP1 to a similar mechanism exists in other granule types, including those triggered by disease-related oxidative stress 26 or other environmental stimuli, remains unknown.”
BackgroundInfluentialMicro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
Boyuklieva, R., & Pilicheva, B. (2022) · Biomedicines · doi:10.3390/biomedicines10071706 · Cited by 82
Pagotto, G. L. D. O., Santos, L. M. O. D., Osman, N., Lamas, C. B., Laurindo, L. F., Pomini, K. T., Guissoni, L. M., Lima, E. P. D., Goulart, R. D. A., Catharin, V. M. C. S., et al. (2024) · Antioxidants · doi:10.3390/antiox13060651 · Cited by 67
“Therefore, oxidative stress has been linked to the onset of a variety of medical conditions, as well as the worsening of pre-existing pathologies [28,124–127].”
Valverde-Salazar, V., Ruiz-Gabarre, D., & García‐Escudero, V. (2023) · Antioxidants · doi:10.3390/antiox12071460 · Cited by 85
“All of them are related to several neuronal functions, such as plasticity, synaptic morphology, and protein synthesis, which can in turn affect memory and neurodegeneration [67,119,129].”
BackgroundInfluentialNatural products in neurodegenerative diseases: recent advances and future outlook
Nahar, L., Charoensup, R., Kalieva, K., Habibi, E., Guo, M., Wang, D., Kvasnica, M., Onder, A., & Sarker, S. D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1529194 · Cited by 83
“Oxidative of pro-in fl ammatory cytokines (Teleanu et al., 2022; Jin et al., 2023).”
InfluentialLuteolin for neurodegenerative diseases: a review
Jayawickreme, K., Ekwosi, C., Anand, A., Andres‐Mach, M., Właź, P., & Socała, K. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00610-8 · Cited by 81
“From molecular point of view, the process of neurode-generation is strongly related to neuroinflammation and oxida - tive stress [128].”
BackgroundLiu, X., Huang, L., Zhang, X., & Xu, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140221 · Cited by 78
Regulation of Keap1-Nrf2 signaling in health and diseases
Xiao, J.-L., Liu, H.-Y., Sun, C., & Tang, C. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09771-4 · Cited by 78
Xu, L., Li, C., Wan, T., Sun, X., Lin, X., Yan, D., Li, J., & Wei, P. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-01965-4 · Cited by 78
Tadijan, A., Vlašić, I., Vlainić, J., Đikić, D., Oršolić, N., & Jembrek, M. J. (2022) · Antioxidants · doi:10.3390/antiox11102049 · Cited by 71
Lin, R., Jin, L., Xue, Y., Zhang, Z., Huang, H., Chen, D., Liu, Q., Mao, Z., Wu, Z., & Tao, Q. (2024) · Advanced Science · doi:10.1002/advs.202306675 · Cited by 85
Zhang, M., Zhang, M., Kou, G., & Li, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1159771 · Cited by 77
“Furthermore, oxidative stress induces brain damage, and neuroinflammation is a crucial factor leading to neurodegenerative diseases (Teleanu et al., 2022).”
BackgroundZeng, L., Yang, K., Yu, G., Hao, W., Zhu, X., Ge, A., Chen, J., & Sun, L. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06807-2 · Cited by 76
“The brain is particularly susceptible to oxidative stress due to its high oxygen demand, abundance of high-redox-active metals (such as iron and copper), and vulnerability of polyunsaturated fatty acids to oxidative damage, while the number of antioxidant factors is relatively limited [174, 175].”
BackgroundXu, L., Zeng, X., Liu, Y., Wu, Z., Zheng, X., & Zhang, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125787 · Cited by 65
Antioxidant Activity of Polysaccharides from the Edible Mushroom Pleurotus eryngii
Petraglia, T., Latronico, T., Fanigliulo, A., Crescenzi, A., Liuzzi, G. M., & Rossano, R. (2023) · Molecules · doi:10.3390/molecules28052176 · Cited by 65
“The generation of ROS and the subsequent oxidative damage are believed to be involved in the pathogenesis of neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) [59,60].”
BackgroundAdvances and perspectives in fluorescent probes for imaging hepatopathy-related biomarkers
Quan, W., Song, W., Zhang, Q. Y., Huang, H., & Lin, W. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215407 · Cited by 65
Bioactive compounds in Hericium erinaceus and their biological properties: a review
Qiu, Y., Lin, G., Liu, W., Fuming, Z., Linhardt, R. J., Wang, X., & Zhang, A. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250152 · Cited by 65
Lomartire, S., & Gonçalves, A. M. M. (2023) · Marine Drugs · doi:10.3390/md21050261 · Cited by 68
“The redox state imbalance is reflected as an increased number of free radicals, ROS, and RNS and a depleted antioxidant defence system, resulting in oxidative stress conditions [48].”
BackgroundLiu, Y., Guttman, L. C., Dawson, V. L., & Dawson, T. M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116174 · Cited by 73
Lehoczki, A., Fekete, M., Jarecsny, T., Zábó, V., Szappanos, Á., Csípő, T., Lipécz, Á., Major, D., Fazekas‐Pongor, V., Varga, P., et al. (2025) · Nutrients · doi:10.3390/nu17172884 · Cited by 77
“Central to neurodegeneration are interrelated molecular mechanisms, including oxidative stress, chronic neuroinflammation, mitochondrial dysfunction, impaired proteostasis, and apoptosis, all contributing to irreversible neuronal damage [3].”
NADH reductive stress drives metabolic reprogramming
Yang, R., Guo, Z., & Li, B. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.07.005 · Cited by 78
Baek, H., Sanjay, S., Park, M., & Lee, H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02950-3 · Cited by 62
“Neuroinflammation and oxidative stress are two critical factors in the pathogenesis of NDs. IL-1β, TNF-α, and IL-6 are the three major pro-inflammatory cytokines released during the inflammatory processes [60].”
BackgroundAlrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alshammari, M. S., Alexiou, A. T., Papadakis, M., Bahaa, M. M., & Batiha, G. E. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12445 · Cited by 64
Oxidative stress and antioxidant therapeutic mechanisms
Liu, H., Jiao, Y., Wang, P., Chen, Y., Xu, M., Zhang, X., Zheng, X., & Yang, Z. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108962 · Cited by 71
Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities
Huang, Z., Jordan, J. D., & Zhang, Q. (2023) · Aging and Disease · doi:10.14336/ad.2023.0628 · Cited by 62
“Inflammatory processes can promote the generation of ROS, while oxidative stress can also activate proinflammatory signaling pathways [116].”
BackgroundCadmium neurotoxicity: Insights into behavioral effect and neurodegenerative diseases
Rezaei, K., Mastali, G., Abbasgholinejad, E., Bafrani, M. A., Shahmohammadi, A., Sadri, Z., & Zahed, M. A. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143180 · Cited by 59
Blossom, V., Ullal, S. D., D’Souza, M. M., Ranade, A. V., Kumar, N. A., & Rai, R. (2025) · 3 Biotech · doi:10.1007/s13205-025-04468-2 · Cited by 64
“These cytokines are directly linked to compromising ROS elimination mechanisms resulting in oxidative stress and stimulation of the major inflammatory response activator NFκB (Teleanu et al 2022).”
Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration
Martano, S., Matteis, V. D., Cascione, M., & Rinaldi, R. (2022) · Nanomaterials · doi:10.3390/nano12142337 · Cited by 69
“Microglial cells are particularly responsive in the presence of imbalances in the brain homeostasis [26].”
BackgroundSPRENGEL, M., Laskowski, R., & Jost, Z. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00902-7 · Cited by 65
“Oxidative stress, which is an accumulation of highly reactive oxygen species is pointed as one of the underlying causes of neurodegenerative disorders [33].”
Overview of Metformin and Neurodegeneration: A Comprehensive Review
Kruczkowska, W., Gałęziewska, J., Buczek, P., Płuciennik, E., Kciuk, M., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18040486 · Cited by 58
The Brain–Gut–Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects
Li, R., Miao, Z., Liu, Y., Chen, X., Wang, H., Su, J., & Chen, J. (2024) · Advanced Science · doi:10.1002/advs.202307971 · Cited by 64
Kurhaluk, N., Kamiński, P., Bilski, R., Kołodziejska, R., Woźniak, A., & Ткаченко, Г. М. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083658 · Cited by 59
“…references, the neuronal damage and disease progression of AD [26], PD [27], Huntington’s [28], and ALS [29,30] is driven by oxidative stress, resulting from an excess of ROS overwhelming the body’s antioxidant defences, leading to lipid peroxidation, protein misfolding, and DNA damage [31,32].”
Fołta, J., Rzepka, Z., & Wrześniok, D. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115177 · Cited by 56
“Common pathophysiological mechanisms include neuroinflammatory processes [7,8], oxidative stress with reactive oxygen species [9–11], mitochondrial dysfunction [12,13], abnormal protein dynamics [14,15], DNA damage [16,17], and neurotrophin dysfunction [18,19].”
Antioxidant activity analysis of collagen peptide-magnesium chelate
Zhang, C., Du, B., Song, Z., Deng, G., Shi, Y., Li, T., & Huang, Y. (2022) · Polymer Testing · doi:10.1016/j.polymertesting.2022.107822 · Cited by 48
Kumar, S., Oh, J., Prabhakaran, P., Awasti, A., Kim, H., & Mathew, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-51728-x · Cited by 48
Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
Scarpa, E., Cascione, M., Griego, A., Pellegrino, P., Moschetti, G., & Matteis, V. D. (2023) · Ibrain · doi:10.1002/ibra.12126 · Cited by 53
“65,66 Since an inflammation state is persistent in NDs 67 AuNPs and AgNPs have shown intrinsic antioxidative properties, 68 capable of scavenging reactive oxygen species (ROS), which play a pivotal role in neuroinflammation ‐ mediated neuronal damage.”
Song, Y., Deng, Q., Li, J., Chen, R., Li, D., Wang, S., Jing, B., & Zhou, X. Y. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123960 · Cited by 51
Barbalho, S. M., Leme Boaro, B., da Silva Camarinha Oliveira, J., Patočka, J., Barbalho Lamas, C., Tanaka, M., & Laurindo, L. F. (2025) · Pharmaceuticals · doi:10.3390/ph18010133 · Cited by 38
Sebghatollahi, Z., Yogesh, R., Mahato, N., Kumar, V., Mohanta, Y. K., Baek, K.-H., & Mishra, A. K. (2025) · Antioxidants · doi:10.3390/antiox14040457 · Cited by 51
“…kinases (MAPKs) pathways [9,10], thereby exacerbating neuroinflammation and contributing to the progression of neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), and multiple sclerosis (MS) [11,12].”
Inflammasomes in neurodegenerative diseases
Wang, Q., Yang, S., Zhang, X., Zhang, S., Chen, L., Wang, W., Chen, N., & Yan, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00459-0 · Cited by 52
“…by innate immune cells of the CNS. Small-molecule mes-sengers, including prostaglandins, nitric oxide (NO), chemokines including macrophage inflammatory protein-1 alpha and granulocyte colony-stimulating factor, and reactive oxygen species (ROS) [28–30], are also involved in neuroinflammation.”
Olivito, I., Avolio, E., Minervini, D., Soda, T., Rocca, C., Angelone, T., Iaquinta, F. S., Bellizzi, D., Rango, F. D., Bruno, R., et al. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114432 · Cited by 51
Aging promotes an increase in mitochondrial fragmentation in astrocytes
Araujo, A. P. B., Vargas, G., Hayashide, L. D. S., Matias, I., Andrade, C. B. V., de Carvalho, J. J., Gomes, F. C. A., & Diniz, L. P. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1496163 · Cited by 43
Anghinoni, J. M., Birmann, P. T., da Rocha, M. J., Gomes, C. S., Davies, M. J., Brüning, C. A., Savegnago, L., & Lenardao, E. J. (2023) · Molecules · doi:10.3390/molecules28217349 · Cited by 44
The Role of IL-17A in Mediating Inflammatory Responses and Progression of Neurodegenerative Diseases
Zheng, M., & Luo, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062505 · Cited by 49
“Inflammation is a critical component of the central nervous system (CNS) microenvironment, playing a dual role in both protection and pathology [3].”
Advanced Nanomedicines for Treating Refractory Inflammation-Related Diseases
Wang, X., Song, X., Feng, W., Chang, M., Yang, J., & Chen, Y. (2025) · Nano-Micro Letters · doi:10.1007/s40820-025-01829-7 · Cited by 52
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Brembati, V., Faustini, G., Longhena, F., & Bellucci, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1197853 · Cited by 44
“Finally, neuroinflammation can also contribute to OS in the PD brain (Mosley et al., 2006; Picca et al., 2020; Teleanu et al., 2022).”
BackgroundMicroalgae as a potential therapeutic drug candidate for neurodegenerative diseases
Parameswari., R. P., & Lakshmi, T. (2022) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2022.09.009 · Cited by 35
Sayyaed, A., Saraswat, N., Vyawahare, N. S., & Kulkarni, A. (2023) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-023-01047-4 · Cited by 44
Zhang, L., Lang, F., Feng, J., & Wang, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117275 · Cited by 46
Guan, Y., Tang, G., Li, L., Shu, J., Zhao, Y., Huang, L., & Tang, J. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01484-9 · Cited by 46
“Oxidative stress, which refers to an imbalance between reactive oxygen species (ROS) production and antioxidant defense mechanisms, is widely considered to be a vital factor in the progression of NDs (Teleanu et al. 2022; Tesco and Lomoio 2022).”
BackgroundBeltrán-Velasco, A. I., Reiriz, M., Uceda, S., & Echeverry‐Alzate, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053010 · Cited by 50
Limitations and Challenges of Antioxidant Therapy
Al‐Madhagi, H., & Masoud, A. M. (2024) · Phytotherapy Research · doi:10.1002/ptr.8335 · Cited by 47
“Post-mortem brain tissue analysis reveals the accumulation of oxidized biomolecules, supporting the role of oxidative stress in these disorders (Teleanu et al. 2022).”
Wang, J., Cao, Y., Yang, L., Zhu, H., Zhang, J., Che, J., Zhuang, R., & Shao, J. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115998 · Cited by 42
Oxidative Stress, Inflammation, and Cellular Senescence in Neuropathic Pain: Mechanistic Crosstalk
Stojanović, B., Bevc, I. M., Stojanovic, M. D., Stojanović, B., Lazarević, T., Spasić, M., Petrovic, M., Stefanovic, I., Marković, M., Nešić, J., et al. (2025) · Antioxidants · doi:10.3390/antiox14101166 · Cited by 53
“Within sensory pathways, Nrf2 activation enhances the transcription of enzymes such as HO-1, NQO1, SOD, catalase, and glutathione-related enzymes [236,248].”
Oxidative stress in the brain–lung crosstalk: cellular and molecular perspectives
Kong, J., Fan, R., Zhang, Y., Jia, Z., Zhang, J., Pan, H., & Wang, Q. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1389454 · Cited by 42
Olloquequi, J., Díaz‐Peña, R., Verdaguer, E., Ettcheto, M., Auladell, C., & Camins, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136928 · Cited by 47
“As explained above, exposure to air pollutants can lead to an increased production of ROS and pro-inflammatory cytokines in the brain, creating a cellular environment that favors the misfolding and aggregation of proteins [124,125].”
BackgroundSong, J., Cho, E., Lee, H., Lee, S., Kim, S., & Kim, J. (2025) · Biosensors · doi:10.3390/bios15020102 · Cited by 46
“AD is a most common ND in which changes in biological substances such as A β and tau proteins lead to cognitive decline, while PD leads to motor and non-motor symptoms due to the aggregation of α -synuclein [1,2].”
Sleep deprivation-induced cognitive impairment: Unraveling the role of neuroinflammation
Yuan, X., & Wang, C. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115419 · Cited by 42
Wan, L., Li, S., Du, J., Li, A., Zhan, Y., Zhu, W., Zheng, P., Qiao, D., Nie, C., & Pan, Q. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c02366 · Cited by 38
Harnessing role of sesamol and its nanoformulations against neurodegenerative diseases
Singh, N., Vishwas, S., Kaur, A., Kaur, H., Kakoty, V., Khursheed, R., Chaitanya, M., Babu, M. R., Awasthi, A., Corrie, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115512 · Cited by 38
“Numerous mechanisms have been proposed to treat NDs, including oxidative damage, neuroinflammation, inhibition of certain biochemical parameters, activation of protective mechanisms, etc [118].”
Photobiomodulation in the aging brain: a systematic review from animal models to humans
Rodríguez‐Fernández, L., Zorzo, C., & Arias, J. L. (2024) · GeroScience · doi:10.1007/s11357-024-01231-y · Cited by 38
“Overall, these findings suggest a potential role for PBM in attenuating neuroinflammation, a common feature of aging-related neurodegenerative diseases [119–121].”
BackgroundThe Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives
Petrikonis, K., Bernatonienė, J., Kopustinskienė, D. M., Casale, R., Davinelli, S., & Saso, L. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081068 · Cited by 39
“By modifying proteins, lipids, and nucleic acids, ROS could alter the function and survival of both neuronal and non-neuronal cells in the nervous system [50].”
BackgroundInfluentialBridging the brain and gut: neuroimmune mechanisms of neuroinflammation and therapeutic insights
Müller, L., & Benedetto, S. D. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1590002 · Cited by 41
Metadata
- Authors
- Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I.
- Affiliations
- Carol Davila University of Medicine and Pharmacy (RO)
- Universitatea Națională de Știință și Tehnologie Politehnica București (RO)
- National Institute for Laser Plasma and Radiation Physics (RO)
- Bucharest Emergency University Hospital (RO)
- Grigore T. Popa University of Medicine and Pharmacy (RO)
- University of Bucharest (RO)
- Corresponding author
- Grumezescu, Alexandru Mihai
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-05-25
- Volume
- 23
- Issue
- 11
- Pages
- 5938
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9180653
- OpenAlex
- W4281569188
- Cited by
- 1,085
- References
- 105
- Citations by year
- 2026: 270 · 2025: 405 · 2024: 254 · 2023: 132 · 2022: 23
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oxidative stress, neuroinflammation, neurodegenerative diseases, reactive oxygen species, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, antioxidants, antioxidant enzymes, non-enzymatic antioxidants
- MeSH terms
- Neuroinflammatory Diseases, Antioxidants, Humans, Reactive Oxygen Species, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.